These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3306546)

  • 1. Plasma levobunolol levels following topical administration with reference to systemic side effects.
    Novack GD; Tang-Liu DD; Kelley EP; Liu SS; Shen CD; Duzman E
    Ophthalmologica; 1987; 194(4):194-200. PubMed ID: 3306546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma treatment with once-daily levobunolol.
    Wandel T; Charap AD; Lewis RA; Partamian L; Cobb S; Lue JC; Novack GD; Gaster R; Smith J; Duzman E
    Am J Ophthalmol; 1986 Mar; 101(3):298-304. PubMed ID: 3513594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of varying drop size on the efficacy and safety of a topical beta blocker.
    Charap AD; Shin DH; Petursson G; Cinotti D; Wortham E; Brown RH; Silverstone DE; Atkins JM; Eto CY; Lue JC
    Ann Ophthalmol; 1989 Sep; 21(9):351-7. PubMed ID: 2683937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of once-daily levobunolol for glaucoma therapy.
    Rakofsky SI; Lazar M; Almog Y; LeBlanc RP; Mann C; Orr A; Lee PF; Friedland BR; Novack GD; Kelley EP
    Can J Ophthalmol; 1989 Feb; 24(1):2-6. PubMed ID: 2653592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of twice-daily levobunolol in the treatment of elevated intraocular pressure.
    Seamone C; LeBlanc R; Saheb N; Novack G
    Can J Ophthalmol; 1988 Jun; 23(4):168-70. PubMed ID: 3293726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pressure lowering effect and side effects of 0.5% and 1.0% levobunolol eyedrops, compared with 0.5% timolol eyedrops in patients with open-angle glaucoma].
    Stryz JR; Merté HJ
    Klin Monbl Augenheilkd; 1985 Dec; 187(6):537-44. PubMed ID: 3912600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended).
    Ophthalmology; 1985 Sep; 92(9):1271-6. PubMed ID: 2865710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol.
    Behrens-Baumann W; Kimmich F; Walt JG; Lue J
    Ophthalmologica; 1994; 208(1):32-6. PubMed ID: 8145982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical 0.5% levobunolol alone or in association with 2% dorzolamide compared with a fixed combination of 0.5% timolol and 2% dorzolamide on intraocular pressure and heart rate in dogs without glaucoma.
    Scardillo A; Pugliese M; De Majo M; Niutta PP; Pugliese A
    Vet Ther; 2010; 11(3):E1-6. PubMed ID: 20960417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of topical levobunolol on retinal, optic nerve head, and choroidal circulation in normal volunteers].
    Ogasawara H; Yoshida A; Fujio N; Konno S; Ishiko S
    Nippon Ganka Gakkai Zasshi; 1999 Jul; 103(7):544-50. PubMed ID: 10443129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group.
    Ophthalmology; 1989 May; 96(5):642-5. PubMed ID: 2664628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
    Călugăru M
    Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of once-daily levobunolol on intraocular pressure in normal-tension glaucoma.
    Inoue K; Ezure T; Wakakura M; Inoue J; Tomita G
    Jpn J Ophthalmol; 2005; 49(1):58-9. PubMed ID: 15692777
    [No Abstract]   [Full Text] [Related]  

  • 14. Ophthalmic beta-blockers: determination of plasma and aqueous humor levels by a radioreceptor assay following multiple doses.
    Phan TM; Nguyen KP; Giacomini JC; Lee DA
    J Ocul Pharmacol; 1991; 7(3):243-52. PubMed ID: 1686051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of the clinical study of a new adrenergic beta blocker levobunolol hydrochloride in healthy subjects and in patients with glaucoma].
    Egorov EA; Shmeleva IA
    Vestn Oftalmol; 1992; 108(3):24-5. PubMed ID: 1481323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the ocular tolerability of a single dose of timolol and levobunolol in healthy normotensive volunteers.
    Sharir M; Zimmerman TJ; Crandall AS; Mamalis N
    Ann Ophthalmol; 1993 Apr; 25(4):133-7. PubMed ID: 8484654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular effects of levobunolol eyedrops in healthy subjects.
    Weiser BA; Feldman F; Ananthanarayan CR; Gilbert BW; Haq A
    Can J Ophthalmol; 1991 Jun; 26(4):211-4. PubMed ID: 1889023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradyarrhythmias secondary to topical levobunolol hydrochloride solution.
    Lin L; Wang Y; Chen Y; Liu M
    Clin Interv Aging; 2014; 9():1741-5. PubMed ID: 25342892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term effects of topical levobunolol on the human retinal circulation.
    Leung M; Grunwald JE
    Eye (Lond); 1997; 11 ( Pt 3)():371-6. PubMed ID: 9373479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter evaluation of levobunolol (Vistagan) in Germany.
    Novack GD; Kelley EP; Lue JC
    Ophthalmologica; 1988; 197(2):90-6. PubMed ID: 3054684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.